Cargando…
Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?
Secondary progressive multiple sclerosis (SPMS) subtype is retrospectively diagnosed, and biomarkers of the SPMS are not available. We aimed to identify possible neurophysiological markers exploring grey matter structures that could be used in clinical practice to better identify SPMS. Fifty-five pe...
Autores principales: | Belvisi, Daniele, Tartaglia, Matteo, Borriello, Giovanna, Baione, Viola, Crisafulli, Sebastiano Giuseppe, Zuccoli, Valeria, Leodori, Giorgio, Ianniello, Antonio, Pasqua, Gabriele, Pantano, Patrizia, Berardelli, Alfredo, Pozzilli, Carlo, Conte, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869727/ https://www.ncbi.nlm.nih.gov/pubmed/35203440 http://dx.doi.org/10.3390/biomedicines10020231 |
Ejemplares similares
-
Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study
por: Tartaglia, Matteo, et al.
Publicado: (2023) -
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence
por: Conte, Antonella, et al.
Publicado: (2020) -
The effect of stimulation frequency on transcranial evoked potentials
por: Leodori, Giorgio, et al.
Publicado: (2022) -
Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia
por: Costanzo, Matteo, et al.
Publicado: (2021) -
Abnormal Temporal Coupling of Tactile Perception and Motor Action in Parkinson’s Disease
por: Conte, Antonella, et al.
Publicado: (2017)